Natural Health TrendsvsTesla

NHTC and TSLA stock compared: price, dividend, valuation and results, from SEC filings.

Natural Health Trends (NHTC) has a market value of $6.1M and Tesla (TSLA) $1.50T. Over the last year, with dividends, NHTC moved -77.7% and TSLA -6.1%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    NHTC$6.1M

    TSLA$1.50T

    TSLA is 245,770 times NHTC

  • Revenue, 12 months

    NHTC$34M

    TSLA$104B

    TSLA is 3,036 times NHTC

  • Net income, 12 months

    NHTC-$1.4M

    TSLA$3.2B

  • Operating margin

    NHTC-5.9%

    TSLA3.4%

    9.3 points apart

  • ROIC

    NHTC-8.3%

    TSLA2.9%

    11.2 points apart

  • P/E

    NHTC–

    TSLA466.5

  • Dividend yield

    NHTC0.0%

    TSLA0.0%

    About the same

  • 5-year return

    NHTC-82.7%

    TSLA+12.4%

    95.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

NHTC-82.7%

TSLA+12.4%

5010015020222023202420252026
Returns by period
PeriodNHTCWith dividendsTSLAWith dividends
1 year since November 14, 2025-77.7%Price -80.3%-6.1%Price -6.1%
3 years since November 16, 2023-80.9%-42.4% a yearPrice -86.8%+62.6%+17.6% a yearPrice +62.6%
5 years since November 15, 2021-82.7%-29.6% a yearPrice -91.0%+12.4%+2.4% a yearPrice +12.4%
10 years since November 17, 2016-91.1%-21.5% a yearPrice -97.2%+2,918.6%+40.6% a yearPrice +2,918.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

NHTCNatural Health TrendsTSLATesla

Valuation

NHTCTSLA
Valuation
Price$0.71$379.74
Market value$6.1M$1.50T
Enterprise value (EV)–$1.47T
P/E–466.5
P/E, 5-year median––
P/B0.416.8
EV/EBIT–422.7
Free cash flow yield–0.2%

Results and growth

NHTCTSLA
Results and growth
Revenue, 12 months$34M$104B
Net income, 12 months-$1.4M$3.2B
Free cash flow, 12 months-$4.7M$3.3B
Earnings per share, 12 months-$0.15$0.91
Revenue growth, year on year-7.4%-2.9%
Revenue growth a year, past-8.5%over 5 years+24.6%over 5 years
EPS growth a year, past–+38.8%over 5 years

Margins and returns on capital

NHTCTSLA
Margins and returns on capital
Gross margin74.3%19.3%
Operating margin-5.9%3.4%
Net margin-4.2%3.1%
ROIC-8.3%2.9%
ROE-7.4%3.8%

Balance sheet

NHTCTSLA
Balance sheet
Cash$18M$45.4B
Total debt$2.6M$16.4B
Net debt / EBITDA–-4.2
Interest cover–10.0×

Dividends and buybacks

NHTCTSLA
Dividends and buybacks
Dividend yield––
Dividend per share, 12 months$0.60–
Dividend growth a year, past+0.0%over 5 years–
Buyback yield––
Shareholder yield84.3%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: NHTC or TSLA

Didn't find what you were looking for?

Ask us
Which is bigger, Natural Health Trends or Tesla?

By market value, Tesla ($1.50T) is about 245,769.6 times Natural Health Trends ($6.1M), at today's prices.

How did NHTC and TSLA stock do over the last 10 years?

Since November 17, 2016, NHTC's price moved -97.2% and TSLA's +2,918.6%. With dividends: NHTC -91.1% (-21.5% a year), TSLA +2,918.6% (+40.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, NHTC or TSLA?

Neither paid a dividend over the last twelve months: Natural Health Trends and Tesla return money to shareholders, if they do, in other ways, such as buybacks.

Which has the higher profit margins, Natural Health Trends or Tesla?

Over the last twelve months, the net margin was -4.2% for Natural Health Trends and 3.1% for Tesla, and the operating margin -5.9% and 3.4%. Revenue was $34M and $104B.

Which is the better investment, Natural Health Trends or Tesla?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.